1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Imbruvica Revenue
1.4 Market by Type
1.4.1 Global Imbruvica Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 5 mg
1.4.3 10 mg
1.4.4 140 mg
1.5 Market by Application
1.5.1 Global Imbruvica Market Share by Application: 2020 VS 2026
1.5.2 Mantle Cell Lymphoma
1.5.3 Chronic Lymphocytic Leukemia
1.5.4 Waldenström’s Macroglobulinemia
1.5.5 Relapsed/Refractory Marginal Zone Lymphoma
1.5.6 Chronic Graft-Versus-Host-Disease
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Imbruvica Market Perspective (2015-2026)
2.2 Global Imbruvica Growth Trends by Regions
2.2.1 Imbruvica Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Imbruvica Historic Market Share by Regions (2015-2020)
2.2.3 Imbruvica Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Imbruvica Market Growth Strategy
2.3.6 Primary Interviews with Key Imbruvica Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Imbruvica Players by Market Size
3.1.1 Global Top Imbruvica Players by Revenue (2015-2020)
3.1.2 Global Imbruvica Revenue Market Share by Players (2015-2020)
3.1.3 Global Imbruvica Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Imbruvica Market Concentration Ratio
3.2.1 Global Imbruvica Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Imbruvica Revenue in 2019
3.3 Imbruvica Key Players Head office and Area Served
3.4 Key Players Imbruvica Product Solution and Service
3.5 Date of Enter into Imbruvica Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Imbruvica Historic Market Size by Type (2015-2020)
4.2 Global Imbruvica Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Imbruvica Market Size by Application (2015-2020)
5.2 Global Imbruvica Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Imbruvica Market Size (2015-2020)
6.2 Imbruvica Key Players in North America (2019-2020)
6.3 North America Imbruvica Market Size by Type (2015-2020)
6.4 North America Imbruvica Market Size by Application (2015-2020)
7 Europe
7.1 Europe Imbruvica Market Size (2015-2020)
7.2 Imbruvica Key Players in Europe (2019-2020)
7.3 Europe Imbruvica Market Size by Type (2015-2020)
7.4 Europe Imbruvica Market Size by Application (2015-2020)
8 China
8.1 China Imbruvica Market Size (2015-2020)
8.2 Imbruvica Key Players in China (2019-2020)
8.3 China Imbruvica Market Size by Type (2015-2020)
8.4 China Imbruvica Market Size by Application (2015-2020)
9 Japan
9.1 Japan Imbruvica Market Size (2015-2020)
9.2 Imbruvica Key Players in Japan (2019-2020)
9.3 Japan Imbruvica Market Size by Type (2015-2020)
9.4 Japan Imbruvica Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Imbruvica Market Size (2015-2020)
10.2 Imbruvica Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Imbruvica Market Size by Type (2015-2020)
10.4 Southeast Asia Imbruvica Market Size by Application (2015-2020)
11 India
11.1 India Imbruvica Market Size (2015-2020)
11.2 Imbruvica Key Players in India (2019-2020)
11.3 India Imbruvica Market Size by Type (2015-2020)
11.4 India Imbruvica Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Imbruvica Market Size (2015-2020)
12.2 Imbruvica Key Players in Central & South America (2019-2020)
12.3 Central & South America Imbruvica Market Size by Type (2015-2020)
12.4 Central & South America Imbruvica Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AbbVie (Pharmacyclics)
13.1.1 AbbVie (Pharmacyclics) Company Details
13.1.2 AbbVie (Pharmacyclics) Business Overview
13.1.3 AbbVie (Pharmacyclics) Imbruvica Introduction
13.1.4 AbbVie (Pharmacyclics) Revenue in Imbruvica Business (2015-2020))
13.1.5 AbbVie (Pharmacyclics) Recent Development
13.2 Johnson & Johnson (Janssen Biotech)
13.2.1 Johnson & Johnson (Janssen Biotech) Company Details
13.2.2 Johnson & Johnson (Janssen Biotech) Business Overview
13.2.3 Johnson & Johnson (Janssen Biotech) Imbruvica Introduction
13.2.4 Johnson & Johnson (Janssen Biotech) Revenue in Imbruvica Business (2015-2020)
13.2.5 Johnson & Johnson (Janssen Biotech) Recent Development
13.3 SP Laboratories
13.3.1 SP Laboratories Company Details
13.3.2 SP Laboratories Business Overview
13.3.3 SP Laboratories Imbruvica Introduction
13.3.4 SP Laboratories Revenue in Imbruvica Business (2015-2020)
13.3.5 SP Laboratories Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
【掲載企業】
AbbVie (Pharmacyclics)、Johnson & Johnson (Janssen Biotech)、SP Laboratories
【免責事項】
https://www.globalresearch.jp/disclaimer